Bioterrorism: A clear and present danger

Nature Medicine

Volumn 7, Issue 12, 2001, Pages 1271-1273

  Clifford Lane, H ^a   La Montagne, J ^a   Fauci, A S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTHRAX; ANTIBIOTIC PROPHYLAXIS; BIOLOGICAL WARFARE; LAW ENFORCEMENT; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; SHORT SURVEY; SMALLPOX; UNITED STATES;

ANTHRAX; BIOLOGICAL WARFARE; BIOTERRORISM; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); NATIONAL INSTITUTES OF HEALTH (U.S.); RESEARCH; RESEARCH SUPPORT; SMALLPOX; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

ANTHRAX; VARIOLA VIRUS;

EID: 0035664569     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1201-1271     Document Type: Short Survey

References (24)

1. Ongoing investigation of anthrax-Florida
2. Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis
3. Bioterrorism-related inhalation anthrax: The first 10 cases reported in the United States
4. Anthrax as a biological weapon: Medical and public health management
5. Postexposure prophylaxis against experimental inhalation anthrax
6. Use of anthrax vaccine in the United States
7. Principles and lessons from the smallpox eradication programme
8. Current status of smallpox vaccine
9. Investigation of tissue culture MNIIVP smallpox vaccine in a coded controlled trial by revaccination of adults by scarification
10. Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections
11. Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge
12. Analysis of the nucleotide sequences of variola virus genomes
13. A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo
14. Search for correlates of protective immunity conferred by anthrax vaccine
15. Anthrax vaccine: Evidence for safety and efficacy against inhalational anthrax
16. An immunogenicity and reactogenicity evaluation of a recombinant Bacillus anthracis protective antigen vaccine
17. Current status of immunization against anthrax: Old vaccines may be here to stay for a while
18. Dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin action in vivo
19. Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity
20. Crystal structure of the anthrax lethal factor
21. Development of a preventive vaccine for Ebola virus infection in primates